TRIB
Income statement / Annual
Last year (2024), Trinity Biotech plc's total revenue was $61.56 M,
an increase of 8.31% from the previous year.
In 2024, Trinity Biotech plc's net income was -$31.79 M.
See Trinity Biotech plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$61.56 M |
$56.83 M |
$62.52 M |
$81.15 M |
$101.98 M |
$90.44 M |
$97.04 M |
$99.14 M |
$99.61 M |
$100.20 M |
| Cost of Revenue |
$40.11 M
|
$37.38 M
|
$52.73 M
|
$54.89 M
|
$53.40 M
|
$52.32 M
|
$55.59 M
|
$57.25 M
|
$56.52 M
|
$53.95 M
|
| Gross Profit |
$21.44 M
|
$19.45 M
|
$22.05 M
|
$33.45 M
|
$48.58 M
|
$38.12 M
|
$41.45 M
|
$41.89 M
|
$43.09 M
|
$46.25 M
|
| Gross Profit Ratio |
0.35
|
0.34
|
0.35
|
0.41
|
0.48
|
0.42
|
0.43
|
0.42
|
0.43
|
0.46
|
| Research and Development Expenses |
$4.54 M
|
$4.38 M
|
$4.14 M
|
$4.50 M
|
$5.08 M
|
$5.33 M
|
$5.37 M
|
$5.66 M
|
$5.04 M
|
$5.07 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$28.82 M
|
$31.15 M
|
$29.17 M
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
| Other Expenses |
$9.25 M
|
$10.96 M
|
-$343.00 K
|
$336.00 K
|
$18.34 M
|
-$91.00 K
|
-$102.00 K
|
-$100.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$42.61 M
|
$46.50 M
|
$32.96 M
|
$29.52 M
|
$48.50 M
|
$32.82 M
|
$34.77 M
|
$36.41 M
|
$35.60 M
|
$32.80 M
|
| Cost And Expenses |
$82.72 M
|
$83.88 M
|
$81.87 M
|
$77.21 M
|
$101.90 M
|
$85.13 M
|
$90.35 M
|
$93.66 M
|
$92.12 M
|
$86.75 M
|
| Interest Income |
$0.00
|
$1.17 M
|
$303.00 K
|
$1.22 M
|
$36.00 K
|
$464.00 K
|
$2.12 M
|
$808.00 K
|
$2.43 M
|
$12.91 M
|
| Interest Expense |
$9.57 M
|
$10.15 M
|
$24.73 M
|
$7.10 M
|
$6.75 M
|
$5.58 M
|
$5.08 M
|
$5.41 M
|
$4.73 M
|
$3.48 M
|
| Depreciation & Amortization |
$1.87 M
|
$1.78 M
|
$2.33 M
|
$2.74 M
|
$3.08 M
|
$4.89 M
|
$4.12 M
|
$5.20 M
|
$5.82 M
|
$5.64 M
|
| EBITDA |
-$16.91 M |
-$24.10 M |
-$16.71 M |
$10.59 M |
$3.20 M |
-$19.52 M |
-$13.98 M |
-$29.27 M |
-$30.92 M |
$19.15 M |
| EBITDA Ratio |
-0.27
|
-0.42
|
-0.27
|
0.13
|
0.03
|
-0.22
|
-0.14
|
-0.3
|
-0.31
|
0.19
|
| Operating Income Ratio |
-0.34
|
-0.48
|
-0.24
|
0.05
|
0
|
0.01
|
0.03
|
0.06
|
0.08
|
0.13
|
| Total Other Income/Expenses Net |
-$9.57 M
|
-$9.88 M
|
-$24.43 M
|
-$5.86 M
|
-$6.72 M
|
-$5.89 M
|
-$2.96 M
|
-$2.21 M
|
-$2.26 M
|
$9.49 M
|
| Income Before Tax |
-$30.73 M
|
-$36.93 M
|
-$43.78 M
|
-$1.92 M
|
-$6.63 M
|
$821.00 K
|
$3.03 M
|
$1.60 M
|
$5.19 M
|
$22.88 M
|
| Income Before Tax Ratio |
-0.5
|
-0.65
|
-0.7
|
-0.02
|
-0.07
|
0.01
|
0.03
|
0.02
|
0.05
|
0.23
|
| Income Tax Expense |
$486.00 K
|
-$59.00 K
|
-$194.00 K
|
-$74.00 K
|
-$620.00 K
|
$4.89 M
|
$637.00 K
|
-$697.00 K
|
$41.00 K
|
$1.08 M
|
| Net Income |
-$31.79 M
|
-$24.02 M
|
-$41.00 M
|
$875.00 K
|
-$6.39 M
|
-$4.07 M
|
$2.39 M
|
-$40.27 M
|
-$100.63 M
|
$21.80 M
|
| Net Income Ratio |
-0.52
|
-0.42
|
-0.66
|
0.01
|
-0.06
|
-0.04
|
0.02
|
-0.41
|
-1.01
|
0.22
|
| EPS |
-1.77 |
-3.2 |
-6 |
0.21 |
-1.54 |
-0.97 |
0.57 |
-9.31 |
-21.91 |
0.96 |
| EPS Diluted |
-1.77 |
-3.2 |
-5.2 |
0.16 |
-1.54 |
-0.8 |
0.46 |
-7.49 |
-17.78 |
0.48 |
| Weighted Average Shares Out |
$17.96 M
|
$7.65 M
|
$6.75 M
|
$4.18 M
|
$4.18 M
|
$4.18 M
|
$4.18 M
|
$4.32 M
|
$4.59 M
|
$4.63 M
|
| Weighted Average Shares Out Diluted |
$17.96 M
|
$7.65 M
|
$7.77 M
|
$5.33 M
|
$4.18 M
|
$5.09 M
|
$5.18 M
|
$5.38 M
|
$5.66 M
|
$5.48 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
